His main research concerns Internal medicine, Fluorouracil, Cancer research, Dihydropyrimidine dehydrogenase and Epidermal growth factor receptor. His studies in Internal medicine integrate themes in fields like Endocrinology, Surgery and Oncology. The concepts of his Oncology study are interwoven with issues in Colorectal cancer, Capecitabine, Pathology, Breast cancer and Bevacizumab.
His Fluorouracil research is multidisciplinary, incorporating elements of Gastroenterology, Pharmacokinetics, Peripheral blood mononuclear cell and Antimetabolite. His Dihydropyrimidine dehydrogenase research incorporates themes from Molecular biology, Biopsy, Dihydropyrimidine dehydrogenase deficiency and DPYD. He has included themes like Epidermal growth factor, Signal transduction and Tyrosine-kinase inhibitor in his Epidermal growth factor receptor study.
His primary scientific interests are in Internal medicine, Oncology, Cancer research, Fluorouracil and Pharmacology. His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Endocrinology. His Oncology research is multidisciplinary, incorporating perspectives in Cetuximab, Head and neck cancer, Capecitabine, Pathology and Breast cancer.
His Cancer research research focuses on subjects like Epidermal growth factor receptor, which are linked to Epidermal growth factor. The concepts of his Fluorouracil study are interwoven with issues in Biochemistry and Antimetabolite. His Pharmacology research includes elements of Methotrexate, Toxicity and Cytotoxicity.
Gérard Milano mostly deals with Internal medicine, Oncology, Cancer research, Cetuximab and Cancer. As part of his studies on Internal medicine, Gérard Milano often connects relevant areas like Single-nucleotide polymorphism. His Oncology study incorporates themes from Toxicity, Breast cancer, Capecitabine and Chemotherapy.
His Cancer research study which covers Immunotherapy that intersects with Melanoma. His work carried out in the field of Cetuximab brings together such families of science as Head and neck cancer, Antibody-dependent cell-mediated cytotoxicity, Epidermal growth factor receptor and Monoclonal. As part of the same scientific family, Gérard Milano usually focuses on Cancer, concentrating on Bioinformatics and intersecting with Precision medicine and MEDLINE.
His primary areas of investigation include Internal medicine, Oncology, Cancer research, Cetuximab and Cancer. His research in Internal medicine intersects with topics in Gastroenterology and Pharmacology. His studies deal with areas such as Head and neck squamous-cell carcinoma, Head and neck cancer, Capecitabine, DPYD and Single-nucleotide polymorphism as well as Oncology.
His biological study spans a wide range of topics, including Monoclonal antibody and Immune system, Immunotherapy. His biological study deals with issues like Antibody-dependent cell-mediated cytotoxicity, which deal with fields such as Cellular immunity and Epidermal growth factor receptor. Many of his research projects under Fluorouracil are closely connected to In patient with In patient, tying the diverse disciplines of science together.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value
Laetitia Marisa;Aurélien de Reyniès;Alex Duval;Alex Duval;Janick Selves.
PLOS Medicine (2013)
Population study of dihydropyrimidine dehydrogenase in cancer patients.
M C Etienne;J L Lagrange;O Dassonville;R Fleming.
Journal of Clinical Oncology (1994)
Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.
O Dassonville;J L Formento;M Francoual;A Ramaioli.
Journal of Clinical Oncology (1993)
Impact of EGFR expression on colorectal cancer patient prognosis and survival
J.-P. Spano;C. Lagorce;D. Atlan;G. Milano.
Annals of Oncology (2005)
Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.
M C Etienne;S Chéradame;J L Fischel;P Formento.
Journal of Clinical Oncology (1995)
A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.
A. Beck;M.C. Etienne;S. Chéradame;J.L. Fischel.
European Journal of Cancer (1994)
Management of hypertension in angiogenesis inhibitor-treated patients
H. Izzedine;S. Ederhy;F. Goldwasser;J. C. Soria.
Annals of Oncology (2009)
Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas.
José Santini;Jean‐Louis Formento;Mireille Francoual;Gérard Milano.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck (1991)
Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.
Ronald A. Fleming;Gerard Milano;Antoine Thyss;Marie-Christine Etienne.
Cancer Research (1992)
Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen.
Antoine Thyss;Johanna Kubar;Gerard Milano;Moise Namer.
The Lancet (1986)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: